Re: BIO-Europe 11/7

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: BIO-Europe 11/7

in response to

Re: BIO-Europe 11/7

Hartland

posted on Nov 07, 2017 10:06AM

Hartland,

I noticed that too, and expected the Zenith presentation to be up by now. Perhaps they will post both the Zenith and Resverlogix presentations at the same time (Resverlogix presents in ~40 minutes). If we don't see them up in the next hour, we can inquire with IR at Resverlogix and Zenith.